VivaZome TBI Therapy
Traumatic Brain Injury (including Post‑Traumatic Epilepsy)
PreclinicalActive
Key Facts
Indication
Traumatic Brain Injury (including Post‑Traumatic Epilepsy)
Phase
Preclinical
Status
Active
Company
About Vivazome
Australian exosome biotech targeting TBI, stroke and neurodegeneration with GMP‑scale EV therapeutics.
View full company profile